Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acute Insulin Effects on Cardiac Function in Diabetes
NCT02962921Phase 4Completed
- Sponsor
- Rambam Health Care Campus
- Start
- Feb 2003
- Primary completion
- May 2003
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of insulin lispro in diabetes mellitus (DM), sponsored by Rambam Health Care Campus. Primary endpoint: Left ventricle ejection fraction at 1 year. Started Feb 2003; status: completed.
02
Drugs
insulin lispro
03
Conditions
diabetes mellitus (DM)
Beyond the preview
Go deeper on NCT02962921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02962921.